Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001102624-11-000574
Filing Date
2011-09-12
Accepted
2011-09-09 18:39:26
Documents
7
Period of Report
2011-08-17

Document Format Files

Seq Description Document Type Size
1 AEOLUS PHARMACEUTICALS 10-Q/A aeolus10qa.htm 10-Q/A 42802
  Complete submission text file 0001102624-11-000574.txt   1176227

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT aols-20110630.xml EX-101.INS 185293
3 XBRL TAXONOMY EXTENSION SCHEMA aols-20110630.xsd EX-101.SCH 10925
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aols-20110630_cal.xml EX-101.CAL 21423
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aols-20110630_def.xml EX-101.DEF 6207
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE aols-20110630_lab.xml EX-101.LAB 79416
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aols-20110630_pre.xml EX-101.PRE 53422
Mailing Address 26361 CROWN VALLEY PARKWAY, SUITE 150 MISSION VIEJO CA 92691
Business Address 26361 CROWN VALLEY PARKWAY, SUITE 150 MISSION VIEJO CA 92691 9494819825
AEOLUS PHARMACEUTICALS, INC. (Filer) CIK: 0001261734 (see all company filings)

EIN.: 561953785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-50481 | Film No.: 111084548
SIC: 2834 Pharmaceutical Preparations